key: cord-0886433-wffyd01f
authors: Sanil, Yamuna; Misra, Amrit; Safa, Raya; Blake, Jennifer M.; Eddine, Ahmad Charaf; Balakrishnan, Preetha; Garcia, Richard U.; Taylor, Rachel; Dentel, John N.; Ang, Jocelyn; Cashen, Katherine; Heidemann, Sabrina M.; Bauerfield, Christian; Sethuraman, Usha; Farooqi, Ahmad; Aggarwal, Sanjeev; Singh, Gautam
title: Echocardiographic Indicators Associated with Adverse Clinical Course and Cardiac Sequelae in Multisystem Inflammatory Syndrome in Children with COVID-19
date: 2021-05-03
journal: J Am Soc Echocardiogr
DOI: 10.1016/j.echo.2021.04.018
sha: 9e9e10e1d1fa634839d2043622984a63577c8239
doc_id: 886433
cord_uid: wffyd01f

Background Multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C) causes significant cardiovascular involvement, which can be a determinant of clinical course and outcome. We aimed to investigate whether echocardiographic measures of ventricular function were independently associated with adverse clinical course and cardiac sequaele in MIS-C. Methods In a longitudinal observational study of 54 MIS-C patients (mean age 6.8 ± 4.4 years, 46% male, 56% African American), measures of ventricular function and morphometry at initial presentation, pre-discharge, and median of 3 and 10 week follow-up were retrospectively analyzed, and were compared to 108 84 age and gender matched normal controls. The magnitude of strain is expressed as an absolute value. Risk stratification for adverse clinical course and outcomes were analyzed between the tertiles of clinical and echo data using ANOVA, univariate and multivariate regression. Results Median LV apical 4-chamber longitudinal (LVA4LS) and global longitudinal strain (LVGLS) at the initial presentation were significantly decreased in MIS-C compared to normal cohort (16.2% and 15.1% vs. 22.3% and 22.0% respectively, p<0.01). Patients in the lowest LVA4LS tertile (<13%) had significantly higher CRP and hs-Troponin, need for intensive care (ICU), mechanical life support, and longer hospital length of stay (LOS) compared to those in the highest tertile (>18.5%) (p<0.01). Initial LVA4LS and LVGLS were normal in 13 of 54 and 10 of 39 patients respectively. There was no mortality. In multivariate regression, only LVA4LS was associated with both the need for ICU and LOS. At median 10 week follow-up to date, 7 of 36 patients (19%) and 6 of 25 patients (24%) had abnormal LVA4LS and LVGLS respectively. Initial LVA4LS<16.2% indicated abnormal LVA4LS at follow-up with 100% sensitivity. Conclusion Impaired LVGLS and LVA4LS at initial presentation independently indicate a higher risk of adverse acute clinical course and persistent subclinical LV dysfunction at 10 weeks follow-up, suggesting they could be applied to identify higher risk children with MIS-C.

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2, COVID-19) has led to widespread morbidity and mortality in the United States and worldwide. Contrary to the initial medical and lay public perception that children with COVID-19 were asymptomatic or minimally symptomatic compared to adult patients, a small subset of these children went on to present with serious multi-organ inflammatory disease [1, 2, 3, 4] . The Centers for Disease Control (CDC) has defined this severe presentation as multisystem inflammatory syndrome in children (MIS-C) [5] . Patients with MIS-C manifest with persistent fever, signs of widespread inflammation, and multisystem organ involvement [5] . The majority of diagnosed patients with MIS-C have been reported to require intensive care therapy with many experiencing prolonged hospitalization and requiring adjunctive therapies including vasopressors, intubation, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO) [6, 7] .

Cardiovascular involvement is common in MIS-C patients with complications including cardiac dysfunction, shock, and myocarditis, which may have implications for clinical course and outcome [6, 7, 8] . Patients who required intensive care therapy were noted to have higher levels of inflammatory biomarkers and cardiac enzymes [9] . The majority of patients affected by MIS-C recover without apparent clinical sequelae. A comprehensive review of cardiac manifestations in patients affected by MIS-C indicates that 6-14% of patients had persistent myocardial dysfunction when evaluated at the time of discharge from hospital [10] . To date, there are no studies to assess if cardiac sequelae persist beyond the acute phase where significant myocardial injury has occurred.

In adult patients with COVID-19, the changes in both left ventricle (LV) and right ventricle (RV) function have been shown to be important indicators of the clinical course and outcomes [11, 12] . Compared to the conventional echocardiographic parameters, LV and RV longitudinal systolic strain measured by twodimensional speckle-tracking echocardiography (2DSTE) evaluate myocardial function accurately and can discern subtle and early changes in ventricular function [13] . Additionally, 2DSTE measured LV apical four chamber peak longitudinal strain (LVA4LS) has been applied to investigate LV function in J o u r n a l P r e -p r o o f different clinical settings for risk stratification and to prognosticate the outcome [14] . However, it has not been utilized in patients with MIS-C in this role.

In this retrospective longitudinal observational cohort study of children with MIS-C we aimed to evaluate echocardiographic measures of ventricular function for risk stratification for adverse clinical course and cardiac sequelae.

This is an observational cohort study of 54 children admitted to Children's Hospital of Michigan who met the CDC case definition of MIS-C between March 2020 and January 2021 [5, Supplemental Table 1 ].

Institutional review board approval with waiver of consent for local data collection was obtained through the Wayne State University institutional review board.

A multidisciplinary team developed the protocol for the management of MIS-C and the longitudinal cardiovascular evaluation (Supplemental Table 2 ). Demographic and clinical data were collected, including history of contact with confirmed or suspected cases of COVID 19. The clinical data included anthropometrics, medical histories, hemodynamics, comorbidities, complications, treatments including intensive care unit (ICU) stay, duration of mechanical ventilation, requirement and duration of vasopressors, VA-ECMO support, length of hospitalization (LOS), therapeutic intervention, and outcomes. The laboratory data included inflammatory markers, such as C reactive protein and cardiac enzymes, including high-sensitivity troponin I (hs-TnI) measured by immunoassay for the detection of cardiac injury.

Patients with positive nasopharyngeal swab testing for SARS-CoV-2 nucleic acid using reverse transcriptase quantitative PCR assay and/or positive qualitative detection of SARS-CoV-2 IgG antibodies or an epidemiologic link to a person with COVID-19 infection were considered confirmed cases of J o u r n a l P r e -p r o o f SARS-CoV-2 infection [5] . Investigations to rule out infectious etiologies were negative for other viral and bacterial alternative plausible diagnoses.

Considering the cardiovascular involvement in MIS-C, initial echocardiography was performed at a median (25%-75% interquartile range, IQR) of 9 (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) hours after admission. Patients had follow-up echocardiograms if they had clinical deterioration during hospitalization, and prior to discharge if indicated. Longitudinal echocardiographic examinations were performed during subsequent outpatient follow-up to date at median 3 weeks and 10 weeks after diagnosis.

Transthoracic Echocardiography: Echocardiograms (Phillips iE 33, Phillips Medical System, Andover, MA) were obtained by experienced sonographers according to American Society of Echocardiography guidelines [15] . All echocardiographic data, including LV strain, LV ejection fraction (LVEF), tricuspid valve annular plane systolic excursion (TAPSE), coronary artery measurements, RV function, and valvular regurgitation, were retrospectively analyzed. LVEF was measured using the 5/6 Area-length method because of the lowest inter-and intra-observer percentage error reported by this method [16] . RV systolic function was assessed by both visual assessment and by TAPSE [17] . Coronary artery morphometry were measured per previously reported guidelines [18] .

Speckle-Tracking Echocardiography: Deformational measures of LV for cardiac mechanics were obtained using 2D STE according to the recommendations of the American Society of Echocardiography and the European Association of Cardiovascular Imaging [19, 20] . To reduce exposure and contamination, STE was assessed off-line by vendor independent 2D cardiac Performance Analysis Software (Tomtec Imaging Systems, Munich, Germany). LV peak longitudinal systolic strain was measured in apical 4 chamber view (LVA4LS) and LV peak circumferential systolic strain (LVCS) in the parasternal short axis view at the level of the mitral valve papillary muscle at the peak of T wave of the ECG just before the closure of the aortic valve. LV global longitudinal systolic strain (LVGLS) was obtained from 2-, 3-, and 4-chamber apical views at the peak of T wave of the ECG just before the closure of the aortic valve.

J o u r n a l P r e -p r o o f LVA4LS was obtained in all 54 patients at initial presentation and in all 36 patients who presented for the follow-up to date ( Figure 1) . LVGLS was only available in 39/54 patients at the initial presentation because apical 2 and 3 chamber views could not be obtained during early stages of pandemic when reduced availability of personal protective equipment and critical condition of patients resulted in challenges in detailed image acquisition. Of the initial 39 patients with available LVGLS, we were able to obtain LVGLS measurements in all 25 of whom came for follow-up to-date at median 10 weeks.

For assessment of ventricular synchrony, we measured the mechanical dispersion, time difference between segments from opposite walls with the shortest and the longest time to peak systolic strain in the apical 4 chamber view, which was defined as maximum opposing wall motion delay (MOWMD).

The strain parameters were compared to those of age and sex matched normal controls who presented to our echocardiography lab for murmur and chest pain evaluation (Supplemental Table 3 ) and were found to have a normal cardiac examination. To achieve a 2:1 ratio of control to cases, 108 normal controls were included.

Coronary artery Z score was calculated based on the formula used by McCrindle et al [21] . Z-scores of volumetric and dimensional parameters, including those of coronary arteries more than 2.0, were considered abnormal [18] . Abnormal findings such as pericardial effusion and valvulitis were additionally recorded. Cardiac MRI was not done during hospitalization due to unstable clinical condition and due to the risk of contamination of the MRI area.

Reproducibility of the strain measurements was assessed using inter-and intra-observer reliability measures on 20 imaging studies from the MIS-C cohort. Each observer performed off-line analysis utilizing the same measurement protocol. The intra-observer variability was assessed by one investigator (Y.S.), who repeated the analysis (blinded to the initial results) on the same cardiac cycles 1 month apart to reduce recall bias. Inter-observer variability was tested for all analyses by a second observer (A.M.)

blinded to the results of the first observer. The categorical variables were reported as numbers and percentages. The normality of continuous variables was tested by Shapiro-Wilk test. Nominal variables were evaluated by Chi squared test. For normally distributed data, analysis of variance (ANOVA) was utilized to determine statistical significance; for non-parametric data, the Kruskal-Wallis test was used. For clinical parameters that were not normally distributed, median and interquartile ranges were generally reported.

The cohort data were divided into three groups of tertiles based on LVA4LS. Similarly, analysis was also performed by dividing cohort into tertiles based on LVEF and LVGLS. Differences in demographic parameters, laboratory values, clinical course, and outcomes among the tertiles were compared for significant differences. The tertiles were used for descriptive purposes for the entire cohort. For receiveroperating characteristic (ROC) curve and regression analysis, LVEF, LVA4LS, and LVGLS were used as continuous variables for correlation.

Univariate linear and logistic regressions, as well as multivariate linear and logistic regressions, were used to determine independent predictors of adverse clinical course and cardiac sequelae. Echocardiographic and laboratory parameters that were found to be correlated in univariate analysis were used in the multivariate models. Given the significant correlation between LVA4LS and LVGLS, LVA4LS was used in the multivariate regression analysis for need for ICU and LOS.

To determine the optimal cutoff value of prognostic LV functional parameters for detecting increased requirement of intensive care during admission and cardiac sequelae at median 10 weeks, ROC curves were used. Reproducibility was assessed by Intra-class correlation coefficient (ICC) analysis and coefficient of variation for inter-and intra-observers. SPSS (version 26, IBM Corp, Armonk, NY) was used to perform the statistical analyses and graphs were created using STATA (version 15.1, stataCorpLLC, Texas, USA). A p value of less than 0.05 was considered statistically significant.

J o u r n a l P r e -p r o o f 

Presenting symptoms included persistent fever (>38.5°C) of acute onset and variable duration accompanied with generalized weakness in 53 of 54 patients Eight patients (15%) had skin rash, cheilitis, conjunctivitis, cervical adenopathy, and erythema of hands and /or feet meeting the criteria for typical Kawasaki disease [18] .

Significant hypotension (systolic blood pressure ≤ 5 th percentile for age, gender and height) with depressed LV systolic function, persistent tachycardia and signs of low cardiac output was present on admission or developed early during the admission in 28 (52%) patients [22] . Three patients had normal LVEF and hypotension due to distributive shock. Twenty-three patients required intravenous inotropic support with eleven needing mechanical ventilation. Acute LV dysfunction with 'myocardial stunning' and fulminant heart failure developed in 4 patients, requiring VA-ECMO support. Indications for initiation of ECMO were cardiogenic shock (n=2), cardiac arrest (n=1), or life threatening arrhythmia refractory to medical management (n=1).

Mild to moderate mitral regurgitation was present in 30 % and mild tricuspid regurgitation in 30 % of patients early in clinical course ( Table 2 ). Mitral regurgitation resolved by 10 weeks follow-up. Mild tricuspid regurgitation was persistent in two patients at 10 weeks follow-up. The available tricuspid regurgitation gradient was normal in these patients. A small pericardial effusion was present in 14 (25%) patients on admission or early in the clinical course and none at 10 weeks follow-up.

Six patients (11.0%) had abnormal coronary artery measurement of one or more segments (Z score 2.07-4.2) on initial inpatient echocardiogram. Two of those patients fulfilled the clinical criteria for typical Kawasaki disease. The coronary artery dilation was diffuse and did not have an aneurysmal appearance.

At the 3 and 10 week follow-up visits, only one patient had abnormal coronary artery measurement (Z score 2.36).

Laboratory data: All patients had elevated C-reaction protein (Table 1) . Significantly elevated high sensitivity troponin I >50 ng/L as evidence of myocardial inflammation with myocardial injury was present in 35 of 54 (64%) patients.

The majority of the patients received first line treatment with intravenous immune globulin (78%) and aspirin (78%). Based on associated co-morbidities, high risk patients received remdesivir (13%). Those with persistent severe inflammatory state received infliximab (24%) and corticosteroids (22%). A subset of patients (n=7, 13%) admitted to the general pediatric floor had decreased myocardial strain; but did not have early institution of anti-inflammatory or immunomodulation (IVIG) treatment.

Their clinical course deteriorated requiring intensive care management and later institution of immunomodulation (IVIG) treatment. In the later days of pandemic, patients with similarly affected myocardial strain received early anti-inflammatory or/and immunomodulation therapy leading to a favorable clinical course.

For the clarity we report the absolute values of all strain in our study. The mean of LVA4LS and LVGLS of age and gender matched normal controls was similar to values reported by a meta-analysis in children (Supplemental Table 3 ) [23] .

Based on data from our normal cohort, LVGLS and A4LS of less than 19.0% and LVCS of less than 20% were defined as abnormal, which were lower than ~2 standard deviations from the mean strain of the normal controls (Supplemental Table 3 ). When compared to normal controls, patients with MIS-C had overall a significantly decreased median LVGLS of 15.1%, LVA4LS of 16.2% and LVCS of 16.3% (p<0.01) at the initial echocardiogram (Table 2, Figure 2 , Figure 3 ). Patients were divided into tertiles based on LVA4LS, with the lowest tertile including patients with LVA4LS< 13%, the middle tertile with patients having LVA4LS between 13% and 18.5 %, and the highest tertile having LVA4LS>18.5 %.

J o u r n a l P r e -p r o o f As seen in Table 1 , compared with patients in the highest tertile, those in the lowest tertile were older, were more likely to have elevated initial and peak C-reactive protein and high sensitivity troponin I ( Figure 4 ) (p<0.05). The lowest tertile also had increased percentage of hypotensive presentation and cardiogenic shock, increased need and longer duration for invasive mechanical ventilation and inotropic support, and increased need for ICU admission, and longer length of stay (LOS) ( p<0.05 for all parameters). All 4 VA-ECMO patients were in the lowest tertile.

Overall findings of clinical course were similar when the patients were divided into tertiles based on LVGLS (Supplemental Table 4a and 4b). Dyssynchrony (MOWD>67 milliseconds) was present in 11 patients (20%) at initial echocardiogram. All patients with dyssynchrony required ICU management but had no hemodynamically significant arrhythmia.

For the entire cohort, the median LVEF (±SD) was 54.2 ± 14.1%. Abnormal LVEF, defined as < 55%, was present in 23 patients (42%) at the initial echocardiogram [24] . Differences in clinical parameters and levels of bio-markers among the three tertiles were statistically significant (Supplemental Table 5a ). Table 2 demonstrates measurements of RV function. The average TAPSE was within normal range for the entire cohort compared to age matched published normative data [25] , with no statistically significant difference between the tertiles. RV function by visual estimation was abnormal in 10 patients (19%).

These patients with abnormal RV function also had significant LV dysfunction secondary to myocardial injury from severe inflammatory response to COVID-19. Table 3 shows the results of the univariate binary logistic and linear regression analysis. LVA4LS, LVGLS, and LVEF at initial echo and initial high sensitivity troponin I correlated with the need for ICU admission, as well as ICU and hospital LOS. The R values were higher for LVA4LS than that of the other independent variables. J o u r n a l P r e -p r o o f Table 4 demonstrates the results of the multivariate binary logistic and linear regression. Initial LVA4LS was associated with the need for ICU admission, while LVEF and initial troponin were not. Initial LVA4LS correlated with both hospital and ICU LOS.

LVA4LS, LVGLS, LVEF, and initial troponin were entered into receiver operator curve (ROC) analysis to estimate the probability of ICU admission ( Figure 5 ). Each of these parameters was statistically significantly associated with ICU admission (p<0.05); the ROC of LVA4LS and LVGLS had higher area under the curves (AUC) than troponin and LVEF curves.

An initial LVA4LS of<16.2% (median value of the MIS-C cohort) indicated the need for ICU admission with 74% sensitivity, 95% specificity and 96% positive predictive value. An initial LVGLS<15.2%

(median value of the MIS-C cohort) indicated the need for ICU admission with 73% sensitivity, 100% specificity, and 100% positive predictive value.

The median length of hospital stay was 5 days for the entire cohort. VA-ECMO was successfully weaned and removed in all 4 patients in median 4.5 days. There was no mortality in our cohort and all were discharged from the hospital. The median high sensitivity troponin normalized before discharge for all tertiles ( Figure 4 ). Of 54 patients, 43 (79%) were seen for follow up at median 3 weeks and 36 (66%) at median 10 weeks after diagnosis to date. All patients were asymptomatic with normal clinical examination at follow-up. All patients had echocardiograms done at follow up.

The LVEF normalized at 10 week follow up in all except in one patient who had an EF of 54 % (Supplemental Table 5b ). Although LVEF normalized at outpatient follow up, 7 of 36 patients who came for follow-up to date (19%) continued to have abnormal LVA4LS (Table 2, Supplemental Figure 1 ). The patients with abnormal LVA4LS at 10 week follow-up were all in the lowest tertile at initial presentation.

Of the 39 patients who had available LVGLS at initial presentation, 25 came for 10 week follow-up to date; of which, 6 (24%) had abnormal LVGLS (Supplemental Table 4b ). Three of these patients had additional follow-up of median 6 months, 2 of which continue to have subclinical decreased LVA4LS (11.3% and 15.9%) and LVGLS (12.3% and 17.0%).

J o u r n a l P r e -p r o o f LVA4LS ≤16.2 % at initial echo was associated with abnormal LVA4LS at 10 weeks follow-up, with sensitivity of 100% and specificity of 66% (p<0.01). LVGLS ≤15.2 % at initial echo also had a sensitivity of 100%, specificity of 74% (p<0.01) and negative predictive value of 100% with regard to abnormal LVGLS at ten weeks follow-up. Conversely, all children with normal LVGLS and LVA4LS at initial echo continued to have normal LV systolic function at median 10 week follow-up.

Initial LVA4LS and initial troponin were associated with LVA4LS at 10 weeks follow-up (Table 4) .

Similarly, LVGLS at initial echocardiogram and initial troponin were associated with LVGLS at 10 weeks follow-up. Initial LVEF did not predict LVEF at 10 weeks median follow-up Synchrony improved over time; however, four (7%) patients still exhibited persistent dyssynchrony at 10

week follow up. The overall number was too small to formally analyze for adverse outcomes. Similarly LVCS improved over time but remained abnormal in two patients at 10 week follow up. RV systolic function was normal at discharge for all patients and continued to be normal at median 10 weeks followup ( Table 2) .

The Intra-class Correlation Coefficient (ICC) for inter-observer variability for LVA4LS was 0.979 (95% confidence interval 0.922 to 0.995, f value 51.612, p <0.001) and LVCS was 0.987 (95% confidence interval 0.931 to 0.997, f value 102.930, p <0.001) indicating minimal inter-observer variability. The ICC for intra-observer variability for LVA4LS was 0.994 (95% confidence interval 0.986 to 0.998, f value 177, p <0.001) indicating minimal intra-observer variability. The coefficient of variation was similar between both observers (27% and 26% respectively) and for repeated measurements for a single observer (26 and 28%).

In this longitudinal observational study with the largest cohort of children with MIS-C from a single center to date, we comprehensively evaluated the prognostic value of LV function using conventional echocardiography and 2D STE. Patients with the greatest degree of LV longitudinal strain impairment at initial stage of MIS-C were more likely to have a higher incidence of hypotension, acute myocardial J o u r n a l P r e -p r o o f injury, inotropic requirement, cardiogenic shock, requirement for VA-ECMO support, and longer hospital length of stay. LVA4LS and LVGLS were able to indicate the risk for subclinical LV dysfunction persistent up to 10 weeks follow up after resolution of acute illness in a subset of patients with MIS-C, independently of other echocardiographic parameters and inflammatory bio-markers. Therefore, a comprehensive assessment of LV strain may be essential for risk stratification in patients with MIS-C at hospital admission for acute adverse clinical course; patients with initial abnormal LV strain may benefit from early institution of specific immunomodulatory and/or anti-inflammatory therapy to favorably impact their clinical course and outcome.

As noted in previous studies, cardiovascular involvement is prevalent in MIS-C [6, 7, 9] . Reports have In our cohort, the clinical presentation and course of MIS-C were similar to those reported from Western Europe and some regions of the U.S with difference in the acuity of clinical course and novel findings of post-infectious persistent subclinical LV dysfunction up to median 10 weeks in children with a relative paucity of preexisting cardiovascular condition [3, 4, 7, 9] . We observed acute heart failure with ventricular dysfunction in the majority of patients and cardiogenic shock in a subset of patients requiring VA-ECMO support (9%) in the course of illness. An elevated high sensitivity troponin I above normal threshold (greater than the 99 th percentile upper reference limit of 50 ng/L) and significant LV dysfunction by strain imaging were indicative of myocardial injury and adverse acute clinical course in a majority of children with MIS-C in our cohort. Detection of decreased myocardial strain at presentation impacted the early initiation of anti-inflammatory and immunomodulatory therapy in the later stages of the pandemic.

It is significant to recognize that patients with MIS-C are at higher risk for adverse clinical course and potential poor outcomes and might benefit from assessment of prognostic risk factors at the onset of the 

A subset of our patients developed reduced RV function in the acute phase; however, unlike many adults with COVD-19, these patients had concomitant significantly decreased LV systolic function due to myocardial damage [11] . Each of these patients had complete recovery of the RV function prior to discharge with no persistent dysfunction at the most recent follow-up. We speculate that the RV in our patient cohort did not have increased hemodynamic overload secondary to lung pathology such as acute respiratory distress syndrome or pneumonia unlike those in adults with COVID-19.

Our study is the first, to our knowledge, in reporting the persistent subclinical cardiac dysfunction at 10 weeks median follow-up in at least 19% of patients who had MIS-C. A previous study in children with MIS-C have shown that a myocarditis-like picture may remain subtle and sub-clinical even with normal EF, in early convalescence but may have distinct dysfunction in systolic and diastolic deformational parameters up to 8 days after diagnosis [29] . In our cohort, the severity of LVA4LS and LVGLS impairment at initial presentation indicated the post-illness cardiac sequelae. MIS-C patients who had LVA4LS of >16.2% at initial echo had normal LVA4LS at 10 weeks follow-up, with a negative predictive value of 100%. LVA4LS of ≤13.0% at initial presentation may indicate incomplete recovery of LV systolic function in short-term. Although clinically asymptomatic, persistence of subclinical cardiac dysfunction in a subset of patients on median 10 weeks follow-up, and persisting up to 6 months in a J o u r n a l P r e -p r o o f smaller subset of patients, in our cohort raises the concern for persistent myocardial injury which warrants long term follow-up.

Our follow-up data in these patients provides support for the recommendations by the American Academy of Pediatrics (AAP) that if a patient had a severe presentation of MIS-C, they should be referred for cardiac evaluation prior to returning to sports [30] .

Although performing 2DSTE for all hospitalized patients with MIS-C may be challenging, our study suggests that specifically focused cardiac ultrasound with 2DSTE for LV function assessments in these patients may help in risk stratification and treatment initiation. Additionally, LVA4LS was found to correlate well with LVGLS, and by itself was found to be useful in predicting clinical course and cardiac outcome.

A limitation of our study is that it is a single center observational study with a relatively low number of patients evaluating short term outcomes, and therefore has limited generalizability. However, in the context of MIS-C, this sample size may be quite significant. The lack of prospective independent validation may be a limitation for use of our sensitivity and specificity cut off values for the general population.

Additionally, not all of our patients have yet followed up in clinic for repeat echocardiograms, which limited our analysis at outpatient follow up. Although LVGLS is considered a standard marker for evaluation of cardiac function, due to challenging clinical conditions, not all patients had echocardiographic views obtained to perform LVGLS analysis at initial presentation. Similarly, we were not able to obtain all parameters of LV diastolic dysfunction due to the same reason. We were unable to assess differences in clinical management and their potential effect on clinical course and outcome.

Additionally, cardiac MRI was not done during hospitalization due to unstable clinical condition and due to the risk of contamination of the MR area. Going forward, we intend to use cardiac MRI in the future for evaluating cardiac function in patients with persistently abnormal LVLS to discern long term cardiac J o u r n a l P r e -p r o o f well-being. For our regression analysis, we did not use brain natriuretic peptide or other markers such as D-dimer as these were not routinely obtained in all of our patients.

Children with MIS-C due to COVID-19 can develop life threatening cardiac decompensation. Our findings demonstrate that in children with MIS-C, impaired LVGLS and LVA4LS at initial presentation are independent indicators of a higher incidence of acute adverse clinical course and risk for persistent subclinical LV dysfunction at median 10 weeks follow up. Consequently, LVLS may be of prognostic value in risk stratification for need of intensive care therapy and for early therapeutic intervention.

Of our cohort, at least 19% continued to have abnormal LVA4LS and LVGLS at 10 weeks median follow up, highlighting that these patients can continue to have subclinical myocardial dysfunction. The patients with significantly abnormal strain at presentation (LVA4LS <13.0%) seemed to be at highest risk for having abnormal strain at 10 week follow up. This group of patients, while clinically asymptomatic at follow up, warrant continued monitoring to ensure that they have no long term cardiac sequelae. This warrants further multicenter studies to assess if any of these subclinical changes may have long term effects.

We acknowledge the dedicated work of our pediatric cardiac sonographers in the acquisition of echocardiograms in all the patients with MIS-C and our team of nurses, respiratory therapists, patient care associates, fellows, residents, and clinicians who worked together to care for these patients.

This research did not receive any specific grant from funding agencies in the public, commercial, or notfor-profit sectors. <0.001 <0.001 a Co-morbidities included: Of 16 patients with comorbidities, 12 had asthma, one had Type 1 diabetes , one had propionic academia, one had proximal renal tubular acidosis with normal kidney function, and one had recently repaired pyloric stenosis. b Acute myocardial injury, per the Beckman Coulter hs-cTnL assay, is defined as a value of > 50 ng/L Abbreviations: LVA4LS = left ventricular peak longitudinal strain in the apical 4 chamber view, BMI= body mass index, ECMO= extracorporeal membrane oxygenation, ICU= intensive care unit, hs= high sensitivity, IQR= interquartile range, DC= discharge Table 1 

 An individual aged <21 years presenting with fever*, laboratory evidence of inflammation**, and evidence of clinically severe illness requiring hospitalization, with multisystem (>2) organ involvement (cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic or neurological) AND  No alternative plausible diagnoses AND  Positive for current or recent SARS-CoV-2 infection by RT-PCR, serology, or antigen test; or exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms.

*Fever >38.0°C for ≥24 hours, or report of subjective fever lasting ≥24 hours **Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and low albumin Additional comments:

 Some individuals may fulfill full or partial criteria for Kawasaki disease but should be reported if they meet the case definition for MIS-C. Echocardiogram protocol includes obtaining apical 4, 3 and 2 chamber views with at least 4 beat loops, parasternal short axis view at base, mitral papillary muscle and apex with 4 beat loops, detailed evaluation of coronary arteries with both 2D as well as color Doppler. Also interrogation of all cardiac valves with 2D, color and spectral Doppler should be performed. Measurements of right ventricular function should be done by visual assessment and tricuspid annular plane systolic excursion. All the patients who had LVGLS data available at initial echocardiogram were included for follow up analysis. Of the 39 patients who had GLS data available at the initial presentation, 25 patients had followed up at median 10 weeks. 14 patients have yet to come for follow up. Of the 25 patients who followed up, GLS was not obtained in one patient due to lack of cooperation from patient. 

Detection of Covid-19 in Children in Early

CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children -United States

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City

Emergency preparedness and response: multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) Health advisory

COVID-19-Associated Multisystem Inflammatory Syndrome in Children -United States

Multisystem Inflammatory Syndrome in Children in New York State

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China

Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics

ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography

Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging

et al for Pediatric Heart Network Investigators. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation

Blood pressure percentile charts to identify high or low blood pressure in children

Reference Ranges of Left Ventricular Strain Measures by Two-Dimensional Speckle-Tracking Echocardiography in Children: A Systematic Review and Meta-Analysis

Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study)

Right ventricular function in infants, children and adolescents: reference values of the tricuspid annular

Cardiology follow-up visits: 1. First follow-up:2 weeks after discharge from the hospital 2

C-reactive protein -mg/L (normal <5) Initial -median (25%-75% IQR) Peak -median (25%-75% IQR) Discharge -median

Initial troponin -median (25%-75% IQR) Initial troponin >50 -no. (%) Peak troponin -median (25%-75% IQR) Peak troponin >50 -no. (%) Discharge troponin -median (25%-75% IQR) Discharge troponin >50 -no

C-reactive protein -mg/L (normal <5) Initial -median (25%-75% IQR) Peak -median (25%-75% IQR) Discharge -median (25%-75% IQR) 129

Peak troponin -median (25%-75% IQR) Peak troponin >50 -no. (%) Discharge troponin -median (25%-75% IQR) Discharge troponin >50 -no. (%) echo --median (IQR) 22 (19, 26) 25 (21, 27) 23 (20, 27) 19 (17, 21) N/A Days from admission to 10 week follow up echo --median (IQR)

Box and whisker plots for each of the tertiles at each echocardiogram with the yellow line in the box plot representing the median. The black dotted line represents -19.0%, the lower limit of normal for LVA4LS. The lowest tertile has significantly reduced LVA4LS compared to the other tertiles